Literature DB >> 7095743

Anticatabolic effect of branched-chain amino acid-enriched solutions in patients with liver cirrhosis.

G Marchesini, M Zoli, C Dondi, G Bianchi, M Cirulli, E Pisi.   

Abstract

An amino acid mixture rich in branched-chain amino acids and poor in aromatic amino acids was infused in six cirrhotics with altered plasma amino acid profile and normal mental state. The effect on muscle protein catabolism, as measured by urinary excretion of 3-methylhistidine, was assessed during two consecutive 3-day period in which patients received the amino acid mixture alone or in a hypertonic dextrose solution. During a 3-day basal period, cirrhotics showed increased rates of 3-methylhistidine excretion as compared to six matched healthy subjects. Both treatments reduced urinary 3-methylhistidine to normal. During treatment, branched-chain amino acids failed to normalize, plasma aromatic amino acid concentrations and ammonia declined, and alanine increased. Branched-chain amino acids are mainly oxidized in skeletal muscle with production of alanine. Reduced muscle protein catabolism following amino acid infusion is consistent with the physiological role of branched-chain amino acids in suppressing protein breakdown and stimulating protein synthesis. Long-term therapy with branched-chain amino acid-enriched mixtures may prove useful in advanced cirrhotics with severe muscle wasting.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7095743     DOI: 10.1002/hep.1840020405

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  11 in total

Review 1.  Nutrition and growth in patients with chronic liver disease.

Authors:  D A Kelly
Journal:  Indian J Pediatr       Date:  1995 Sep-Oct       Impact factor: 1.967

Review 2.  Adequacy and support of physiological functions in the acutely ill cirrhotic patient.

Authors:  I Giovannini; G Boldrini; C Chiarla; M Castagneto; G Sganga; G Tramutola; F Caracciolo; G Castiglioni
Journal:  World J Surg       Date:  1987-04       Impact factor: 3.352

3.  Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths.

Authors:  S T Fan; C M Lo; C L Liu; C M Lam; W K Yuen; C Yeung; J Wong
Journal:  Ann Surg       Date:  1999-03       Impact factor: 12.969

4.  Effect of long-term oral supplementation with branched-chain amino acid granules on the prognosis of liver cirrhosis.

Authors:  T Yoshida; Y Muto; H Moriwaki; M Yamato
Journal:  Gastroenterol Jpn       Date:  1989-12

Review 5.  [Catabolism and artificial nutrition of the internal medicine intensive care patient].

Authors:  L S Weilemann
Journal:  Z Ernahrungswiss       Date:  1989-09

6.  Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group.

Authors:  Nicolaas E P Deutz; Jürgen M Bauer; Rocco Barazzoni; Gianni Biolo; Yves Boirie; Anja Bosy-Westphal; Tommy Cederholm; Alfonso Cruz-Jentoft; Zeljko Krznariç; K Sreekumaran Nair; Pierre Singer; Daniel Teta; Kevin Tipton; Philip C Calder
Journal:  Clin Nutr       Date:  2014-04-24       Impact factor: 7.324

7.  Differential effects of hyperinsulinemia and hyperaminoacidemia on leucine-carbon metabolism in vivo. Evidence for distinct mechanisms in regulation of net amino acid deposition.

Authors:  P Tessari; S Inchiostro; G Biolo; R Trevisan; G Fantin; M C Marescotti; E Iori; A Tiengo; G Crepaldi
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

8.  Frequency of upper gastrointestinal lesions in patients with liver cirrhosis.

Authors:  C Sacchetti; M Capello; P Rebecchi; L Roncucci; G Zanghieri; A Tripodi; M Ponz de Leon
Journal:  Dig Dis Sci       Date:  1988-10       Impact factor: 3.199

9.  Oral supplementation with branched-chain amino acids improves survival rate of rats with carbon tetrachloride-induced liver cirrhosis.

Authors:  K Kajiwara; M Okuno; T Kobayashi; N Honma; T Maki; M Kato; H Ohnishi; Y Muto; H Moriwaki
Journal:  Dig Dis Sci       Date:  1998-07       Impact factor: 3.199

10.  Effect of branched-chain amino acid-enriched nutritional supplementation on interferon therapy in Japanese patients with chronic hepatitis C virus infection: a retrospective study.

Authors:  Yumiko Nagao; Takumi Kawaguchi; Tatsuya Ide; Michio Sata
Journal:  Virol J       Date:  2012-11-22       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.